New drug shortages increased nearly 30% last year to their highest level in almost five years, according to a report released last week by the Senate Homeland Security and Governmental Affairs Committee for a hearing on the issue. The report calls for actions to prioritize approvals for critical drugs in shortage; invest in advanced manufacturing to produce critical drugs domestically; and better monitor supply chain vulnerabilities and anticipate possible shortages, among other recommendations. AHA staff and members were interviewed for the report.

Related News Articles

Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…
Headline
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its…
Headline
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages. In comments submitted…
Headline
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages.   …
News
Pfizer will ship certain sterile injectable products directly to customers under an emergency ordering process implemented yesterday due to high demand for the…